TCL Archive FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate October 8, 2010
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Clinton Budget Provides 4.7% Increase For NIH; $118 Million Raise for NCI February 11, 1994
TCL Archive NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement. September 29, 2000
